Document is current
Any future updates will be listed below
-
Authors
Khaddour, Karam https://orcid.org/0000-0001-6697-3516
Musiek, Amy
Cornelius, Lynn A.
Dehdashti, Farrokh
Westervelt, Peter
Fields, Ryan
Ansstas, George
- License Information
-
More Information
Article History
Received: 23 August 2019
Accepted: 30 October 2019
First Online: 4 December 2019
Ethics approval and consent to participate
: Not Applicable.
: Written and verbal consent were obtained from the patient prior to submission for publication. A copy of the written consent form is available at the editorial office for this journal.
: KK reports no conflict of interest. AM reports: kyowa kirin- advisory board, Helsinn- Advisory board, Elorac, Sologenix MiRagen (investigator), investigator in CITN study “embrolizymab and IFN-gamma in MF/SS and synovial sarcoma”. LC reports no conflict of interest. FD reports no conflict of interest. PW reports no conflict of interest. RF reports no conflict of interest. GA speaker bureau for Merck.
